Navigation Links
Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease

roughout the duration of the 12-month study, or in the subsequent two years since the study formally ended.

About Neurologix

Neurologix, Inc. is a development-stage company engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system utilizing gene therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease, epilepsy and other neurodegenerative and metabolic disorders. Neurologix's core technology, "NLX," is currently in the clinical development stages, having recently been tested in a company-sponsored Phase I human clinical trial to treat Parkinson's disease.

Cautionary Statement Regarding Forward-looking Statements

This news release includes certain statements of the Company that may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and which are made pursuant to the Private Securities Litigation Reform Act of 1995. These forward-looking statements and other information relating to the Company are based upon the beliefs of management and assumptions made by and information currently available to the Company. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, or performance, as well as underlying assumptions and statements that are other than statements of historical fact. When used in this document, the words "expects," "promises," "anticipates," "estimates," "plans," "intends," "projects," "predicts," "believes," "may" or "should," and similar expressions, are intended to identify forward-looking statements. These statements reflect the current view of the Company's management with respect to future events. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any futu
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:10/7/2008)...alif., Oct. 7 /- Aerovance Inc. today...m a Phase I trial of its Aerovant,inhalation powde...nce of,local irritancy following asthma patients, ...se will be the highest of three doses investigated...h is scheduled to begin early,next year. Evidence ...
(Date:10/7/2008)...panded to Eight On-Demand Tests for Use on the Gen... SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ ...ase of Xpert(TM) vanA/vanB as a European CE,IVD Ma...o Diagnostic,Medical Devices. The test delivers ra... most commonly associated with vancomycin-resistan...
(Date:10/6/2008).... 6 /PRNewswire-USNewswire/ -- "A return to the us...lopment is without scientific,justification," acco...ernatives to Laboratory Animals (ATLA). "An Assess...search" concludes that vaccine responses in,chimpa...nd that claims of,chimpanzees, critical role and i...
(Date:10/6/2008)...ss Promising Research at The American College of N...g, WASHINGTON, Oct. 6 /- New researc...niors was presented at The American College of,Nut...ical Applications of,Probiotics in Health and Dise...cs, aging, and nutrition discussed the potential u...
Breaking Medicine Technology:Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Bushs Budget Proposal Would Cut Medicare Funding 10974 1Bushs Budget Proposal Would Cut Medicare Funding 10974 2Bushs Budget Proposal Would Cut Medicare Funding 10974 3Bushs Budget Proposal Would Cut Medicare Funding 10974 4Over 300 Children Are Given New Smiles 10972 1Over 300 Children Are Given New Smiles 10972 2Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 1Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 2Shareholder Class Action Filed Against American Dental Partners Inc by the Law Firm of Schiffrin Barroway Topaz 26 Kessler LLP 10970 3Will This President Never Learn 3F Another Budget Another Increase to Ineffective Abstinence Only Programs 10968 1Will This President Never Learn 3F Another Budget Another Increase to Ineffective Abstinence Only Programs 10968 2
...YTON, Ohio, June 08, 2007,/PRNewswire-FirstCall/ -...tic Fibrosis Society Annual,Meeting. ..., -- Exocrine pancreatic insufficiency (EPI) is...lly produced by,the pancreas that can result from ...ibrosis, chronic pancreatitis, and , , pancr...
... Patients Taking Trexima were Migraine Free,Compar... -- New data from two large,trials show that Trexi...e as placebo in eliminating all traditional migrai...attacks with just,one tablet. The findings will be...Meeting of the American Headache Society. , In add...
Other Medicine Technology:Eurand to Present Zentase Phase III Data 2Eurand to Present Zentase Phase III Data 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks 4
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...studies have suggested that drinking a lot of coff...h weight and may result in miscarriage or prematur...rs finds that there is no indication of a link bet...egnancy outcome. The study began with the recrui...
...has okayed the issue of compulsory licenses for in...,// a move, not likely to sit well with pharmaceut...onfirmed that the laws are in place and are effect..., the drugs are meant for treating HIV-AIDS and he...
...s at UC Irvine have discovered that learning appea...at are the hallmarks of Alzheimer's disease.// The...ir minds active, can help delay the onset of this ...s in the Jan. 24 issue of the Journal of Neuroscie...
...y of Miami researchers report that supplements of ...progression of HIV. // Deficiencies in selenium h...nce suggests that supplements of the nutrient can ... the researchers report in the Jan. 22 issue of th...
Other Medicine News:Health News:Learning Slows Physical Progression of Alzheimer's Disease: Study 2Health News:Selenium Supplements May Slow Progression of HIV: Report 2Health News:Selenium Supplements May Slow Progression of HIV: Report 3
...eica ASP200 is an advanced smart processor for par...ne histopathology applications. Proven and enhance... smart operating software are the hallmark of the ...ed and the software includes a variety of SMART fe...
The electronic, motorized rotary microtomes are designed for all applications of paraffin, semi-thin (HM 360), and hard specimens in clinical, research, and industrial labs. These instruments display
...eica RM2255 rotary microtome, designed for fully m...bedded specimens, offers a broad application spect...ory. This microtome meets the requirements of user...c microtome for their laboratory. The entire acces...
State-of-the-Art modular embedding station providing performance and ease of use to meet the needs of the most demanding user.
Medicine Products: